A Spotlight On Meridian Bioscience, Inc.’s (NASDAQ:VIVO) Fundamentals
Building up an investment case requires looking at a stock holistically. Today I’ve chosen to put the spotlight on Meridian Bioscience, Inc. (NASDAQ:VIVO) due to its excellent fundamentals in more than one area. VIVO is a notable dividend-paying company that has been able to sustain great financial health over the past. In the following section, I expand a bit more on these key aspects. If you’re interested in understanding beyond my broad commentary, read the full report on Meridian Bioscience here.
Excellent balance sheet average dividend payer
VIVO is financially robust, with ample cash on hand and short-term investments to meet upcoming liabilities. This indicates that VIVO has sufficient cash flows and proper cash management in place, which is a crucial insight into the health of the company. VIVO appears to have made good use of debt, producing operating cash levels of 0.69x total debt in the prior year. This is a strong indication that debt is reasonably met with cash generated.
VIVO’s profit levels are sufficient enough to reinvest and payout as dividends, which has exceeded the low-risk savings rate, adequately rewarding investors for taking on the risk of holding a stock over a riskless asset. However, it is important to remember that dividend yields are a function of stock prices and corporate profits, which can be volatile.
Next Steps:
For Meridian Bioscience, I’ve put together three pertinent aspects you should further research:
Future Outlook: What are well-informed industry analysts predicting for VIVO’s future growth? Take a look at our free research report of analyst consensus for VIVO’s outlook.
Historical Performance: What has VIVO’s returns been like over the past? Go into more detail in the past track record analysis and take a look at the free visual representations of our analysis for more clarity.
Other Attractive Alternatives : Are there other well-rounded stocks you could be holding instead of VIVO? Explore our interactive list of stocks with large potential to get an idea of what else is out there you may be missing!
To help readers see past the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price-sensitive company announcements.
The author is an independent contributor and at the time of publication had no position in the stocks mentioned. For errors that warrant correction please contact the editor at editorial-team@simplywallst.com.
